Antabio
Jean-Michel Petit serves as Investment Director at IRDI Capital Investissement and holds board member positions at multiple companies, including ANTABIO, Dionymer, Ademtech, and Solvionic. Jean-Michel Petit earned an MBA in International Business and Finance from McGill University between 1995 and 1997 and previously obtained a Master of Science degree in Chemistry from Université de Montréal from 1993 to 1995.
This person is not in the org chart
This person is not in any teams
Antabio
Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.